AstraZeneca COVID-19 vaccine shows 74% efficacy in large US trial
AstraZeneca Plc's COVID-19 vaccine demonstrated 74 percent efficacy at preventing symptomatic disease, a figure that increased to 83.5 percent in people aged 65 and older, according to long-awaited results of the company's US clinical trial published on Wednesday.
from bdnews24.com - Home https://ift.tt/3iDtcfB
from bdnews24.com - Home https://ift.tt/3iDtcfB
No comments